These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1124 related articles for article (PubMed ID: 19321428)
1. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Belouzard S; Chu VC; Whittaker GR Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5871-6. PubMed ID: 19321428 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner. Lavie M; Dubuisson J; Belouzard S J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. Madu IG; Roth SL; Belouzard S; Whittaker GR J Virol; 2009 Aug; 83(15):7411-21. PubMed ID: 19439480 [TBL] [Abstract][Full Text] [Related]
5. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein. Matveev EV; Ponomarev GV; Kazanov MD Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333 [TBL] [Abstract][Full Text] [Related]
6. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Follis KE; York J; Nunberg JH Virology; 2006 Jul; 350(2):358-69. PubMed ID: 16519916 [TBL] [Abstract][Full Text] [Related]
8. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin. Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808 [TBL] [Abstract][Full Text] [Related]
9. Elastase-mediated activation of the severe acute respiratory syndrome coronavirus spike protein at discrete sites within the S2 domain. Belouzard S; Madu I; Whittaker GR J Biol Chem; 2010 Jul; 285(30):22758-63. PubMed ID: 20507992 [TBL] [Abstract][Full Text] [Related]
10. Proteolytic activation of the spike protein at a novel RRRR/S motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells. Yamada Y; Liu DX J Virol; 2009 Sep; 83(17):8744-58. PubMed ID: 19553314 [TBL] [Abstract][Full Text] [Related]
11. Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion. Jaiswal D; Kumar U; Gaur V; Salunke DM Protein Sci; 2023 Mar; 32(3):e4575. PubMed ID: 36691733 [TBL] [Abstract][Full Text] [Related]
12. Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Millet JK; Whittaker GR Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15214-9. PubMed ID: 25288733 [TBL] [Abstract][Full Text] [Related]
13. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein. Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791 [TBL] [Abstract][Full Text] [Related]
14. Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion. Barrett CT; Neal HE; Edmonds K; Moncman CL; Thompson R; Branttie JM; Boggs KB; Wu CY; Leung DW; Dutch RE J Biol Chem; 2021 Jul; 297(1):100902. PubMed ID: 34157282 [TBL] [Abstract][Full Text] [Related]
15. SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Madu IG; Belouzard S; Whittaker GR Virology; 2009 Oct; 393(2):265-71. PubMed ID: 19717178 [TBL] [Abstract][Full Text] [Related]
16. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Peacock TP; Goldhill DH; Zhou J; Baillon L; Frise R; Swann OC; Kugathasan R; Penn R; Brown JC; Sanchez-David RY; Braga L; Williamson MK; Hassard JA; Staller E; Hanley B; Osborn M; Giacca M; Davidson AD; Matthews DA; Barclay WS Nat Microbiol; 2021 Jul; 6(7):899-909. PubMed ID: 33907312 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation. Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407 [TBL] [Abstract][Full Text] [Related]
18. Trypsin enhances SARS-CoV-2 infection by facilitating viral entry. Kim Y; Jang G; Lee D; Kim N; Seon JW; Kim YH; Lee C Arch Virol; 2022 Feb; 167(2):441-458. PubMed ID: 35079901 [TBL] [Abstract][Full Text] [Related]
19. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles. Du S; Xu W; Wang Y; Li L; Hao P; Tian M; Wang M; Li T; Wu S; Liu Q; Bai J; Qu X; Jin N; Zhou B; Liao M; Li C J Virol; 2022 Mar; 96(6):e0189721. PubMed ID: 35045269 [TBL] [Abstract][Full Text] [Related]
20. A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry. Begum F; Srivastava AK; Tripathi PP; Ray U J Med Virol; 2023 May; 95(5):e28796. PubMed ID: 37218551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]